Propanc Biopharma, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021
May 14, 2021 at 05:25 pm EDT
Propanc Biopharma, Inc. announced earnings results for the third quarter ended March 31, 2021. For the third quarter, the company announced operating loss was USD 427,952 compared to USD 607,168 a year ago. Net loss was USD 417,738 compared to USD 2.585 million a year ago. For the nine months, operating loss was USD 1.085 million compared to USD 2.900 million a year ago. Net loss was USD 1.246 million compared to USD 5.944 million a year ago.